Chemical Identity and Physicochemical Properties

Cyclohexanesulfonamide (molecular formula C₆H₁₃NO₂S; MW 163.24 g/mol) belongs to the sulfonamide class of compounds, characterised by a sulfonyl group (–SO₂) directly bonded to an amine nitrogen (–NH₂). The cyclohexane ring imparts appreciable lipophilicity relative to aliphatic short-chain sulfonamides, while the sulfonamide moiety confers moderate water solubility through hydrogen-bond donation and acceptance.

The compound typically presents as a white to off-white crystalline powder at ambient temperature. The sulfonamide N–H is weakly acidic (pKa typically in the range of 9–11 for primary sulfonamides), allowing selective deprotonation under mildly basic conditions for N-alkylation or N-acylation reactions. Its melting point and exact solubility should be confirmed from the current product certificate of analysis.

Synthetic Applications and Research Uses

As a primary sulfonamide, cyclohexanesulfonamide serves multiple roles in synthetic chemistry:

• Building block in medicinal chemistry: The sulfonamide pharmacophore is present in numerous bioactive compounds. Cyclohexanesulfonamide can be elaborated via N-functionalization (alkylation, arylation, acylation) to generate libraries of sulfonamide derivatives for biological screening.
• Nitrogen-donor ligand precursor: In coordination chemistry, sulfonamide nitrogens can coordinate to metal centres. Cyclohexanesulfonamide and its N-substituted derivatives have been investigated as ligand components in catalytic systems.
• Coupling partner in transition-metal catalysis: Sulfonamides participate in copper- or palladium-mediated C–N bond-forming reactions (e.g., Buchwald–Hartwig-type amination), enabling access to N-sulfonyl heterocycles and aryl sulfonamides.
• Protecting group strategy: The –SO₂ group activates the nitrogen for directed reactions while the cyclohexyl moiety can modulate steric and electronic properties of intermediates.

Researchers should consult primary literature for specific reaction conditions, as substrate scope and yields depend heavily on the catalyst system and solvent employed.

Safe Handling, Storage, and Laboratory Precautions

Although cyclohexanesulfonamide is not classified among highly hazardous reagents, standard laboratory precautions must be observed:

• Personal protective equipment (PPE): Wear appropriate gloves (nitrile recommended), safety glasses, and a lab coat when handling the solid or its solutions. Use a dust mask or work in a fume hood when weighing fine powder to avoid inhalation of particulates.
• Storage: Store in a tightly sealed container in a cool, dry, well-ventilated area away from strong oxidisers and moisture. Refer to the product Safety Data Sheet (SDS) for specific storage temperature recommendations.
• Waste disposal: Dispose of waste material in accordance with local, regional, and national regulations governing sulfonamide-containing chemical waste.
• First aid: In case of skin or eye contact, rinse thoroughly with water. If inhaled, move to fresh air. Seek medical attention if symptoms persist. Consult the SDS for complete first-aid measures.

Note: Always consult the current SDS provided with the product before use. Hazard classifications and precautionary statements should be verified against the latest regulatory information.

Quality, Purity, and Regulatory Considerations

For reproducible research outcomes, reagent purity is critical. When selecting cyclohexanesulfonamide for sensitive applications, consider the following:

• Purity grade: Verify the purity specification on the certificate of analysis (CoA). High-purity grades (≥97–98% by HPLC or GC) are recommended for synthesis and analytical work to minimise interference from impurities.
• Characterisation data: Confirm identity via ¹H NMR, ¹³C NMR, IR spectroscopy, and mass spectrometry data provided on the CoA. Typical ¹H NMR (in DMSO-d₆ or CDCl₃) should show the cyclohexyl CH and NH₂ resonances consistent with reported literature values.
• Lot-to-lot consistency: Request CoA documentation for each batch to ensure consistent quality, especially for multi-step synthesis campaigns or regulatory filings.
• Regulatory status: Cyclohexanesulfonamide is a research reagent not approved for human or veterinary therapeutic use. Users are responsible for compliance with applicable regulations when handling and disposing of this compound.